Clinical trial Recruiting at 14 sites Interventional Ages 12 to 17

WE BEAT: a 5-week online wellbeing program for teens with congenital heart disease

Official title: A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD Study

Run by Carelon Research · NCT07525843 · Data updated 2026-11-12

This study tries a 5-week online group wellbeing program to see if it helps teens aged 12–17 with moderate-to-severe congenital heart disease become more resilient and improve quality of life compared with usual care.

More Congenital Heart Disease trials

Quick facts

Study typeInterventional
Ages12 Years to 17 Years
SexAll
Enrollment390 (estimated)
SponsorCarelon Research
Academic / other
Locations14 sites (Stanford, California and 13 other locations)
StatusRecruiting
StartedApril 20, 2026
Main results expectedApril 2029
Study endsJune 2029
Registry record updatedOctober 16, 2026
Trial IDNCT07525843 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are 12–17-year-olds with moderate or severe complexity congenital heart disease who speak English or Spanish, receive cardiology care at a participating PHN or PHN auxiliary site, and whose parent/guardian and the teen can provide consent/assent and complete study activities.

Probably not a fit

Patients unlikely to benefit include those with simple/mild CHD, prior heart transplant, non-structural heart disease, significant cognitive or developmental barriers to participation, recent suicidality/psychosis, or who are medically unable to take part or use telemedicine.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adolescents with moderate-to-severe congenital heart disease are randomized to either a 5-week telemedicine group wellbeing and skill-building program (WE BEAT) or usual care and followed for about six months. The study uses participant-reported outcome measures to track resilience, quality of life, and other psychosocial domains before and after the intervention. Clinical data are also collected to explore links between self-reported wellbeing and medical outcomes. The pragmatic design emphasizes remote delivery and real-world applicability across multiple pediatric cardiology centers.

Why it matters

Potential benefit: If successful, the program could boost resilience and quality of life for teens with moderate-to-severe CHD and provide a scalable telehealth support option.

How similar studies have gone: Resilience and wellbeing programs for adolescents have shown benefits in other populations, but telemedicine group programs specifically targeted to moderate-to-severe CHD are less well studied and relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 12-17 years old
* CHD of moderate or severe complexity (Class II/III, 2018 AHA/ACC ACHD, Table 4)
* English or Spanish language proficiency
* Receives cardiology care at a PHN or PHN auxiliary site
* Parent or guardian and participant willing to comply with protocol and provide written/electronic informed consent and assent

Exclusion Criteria:

* CHD of mild or simple complexity (Class I, 2018 AHA/ACC ACHD, Table 4)
* Prior heart transplant to treat CHD
* Heart disease that is not classified as structural CHD (e.g., connective tissue disease, genetic cardiomyopathy, or acquired heart disease)
* Cognitive or developmental conditions that limit program participation and/or ability to complete self-reported measures as determined by a primary cardiology clinician
* Suicidality, homicidality, or psychosis in the past 12 months as per medical chart review, clinician report, or eligibility screening
* Medically unable to participate (e.g., intubated, unable to respond verbally, active delirium)

Where it's running

  • Stanford School of Medicine
    Stanford, California, United States
    Recruiting
  • Children's Hospital Colorado
    Aurora, Colorado, United States
    Recruiting
  • Emory University School of Medicine
    Atlanta, Georgia, United States
    Recruiting
  • University of Kentucky College of Medicine
    Lexington, Kentucky, United States
    Recruiting
  • Boston Children's Hospital
    Boston, Massachusetts, United States
    Recruiting
  • University of Michigan Health System
    Ann Arbor, Michigan, United States
    Recruiting
Show 8 more locations
  • Washington University School of Medicine
    St Louis, Missouri, United States
    Recruiting
  • Icahn School of Medicine at Mount Sinai
    New York, New York, United States
    Recruiting
  • Columbia University Irving Medical Center
    New York, New York, United States
    Recruiting
  • Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio, United States
    Recruiting
  • Children's Hospital of Philadelphia
    Philadelphia, Pennsylvania, United States
    Recruiting
  • Children's Hospital of Pittsburgh
    Pittsburgh, Pennsylvania, United States
    Recruiting
  • Medical University of South Carolina
    Charleston, South Carolina, United States
    Recruiting
  • Primary Children's Hospital, University of Utah
    Salt Lake City, Utah, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.